The Vanguard Group 13D and 13G filings for Charles River Laboratories International, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:01 pm Purchase |
2023-12-29 | 13G | Charles River Laboratories International, Inc. CRL |
The Vanguard Group | 5,980,236 11.660% |
23,276 (+0.39%) |
Filing |
| 2023-02-09 11:12 am Purchase |
2022-12-30 | 13G | Charles River Laboratories International, Inc. CRL |
The Vanguard Group | 5,956,960 11.710% |
87,835 (+1.50%) |
Filing |
| 2022-02-09 3:33 pm Purchase |
2021-12-31 | 13G | Charles River Laboratories International, Inc. CRL |
The Vanguard Group | 5,869,125 11.630% |
841,221 (+16.73%) |
Filing |
| 2021-02-10 10:46 am Sale |
2020-12-31 | 13G | Charles River Laboratories International, Inc. CRL |
The Vanguard Group | 5,027,904 10.110% |
-291,472 (-5.48%) |
Filing |